EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Sex differences in the initiation of antithrombotic therapy in patients with atrial fibrillation in Germany

Jamschid Sedighi, Mark Luedde, Boris Dinov, Philipp Bengel, Priyanka Boettger, Christian Tanislav, Samuel Sossalla, Karel Kostev

Clinical Research in Cardiology · 2025

DOI: 10.1007/s00392-025-02757-7 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Research in Cardiology, 2025. Verfasst von Jamschid Sedighi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Clinic I, Cardiology and Angiology, Justus-Liebig-University, Klinikstraße 33, 35392, Giessen, Germany. Jamschid.Sedighi@innere.med.uni-giess…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Fibrinolytic Agents, Stroke, Practice Patterns, Physicians'. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Justus-Liebig-Universität Gießen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims Despite guidelines recommending antithrombotic therapy for atrial fibrillation (AF) patients, differences in treatment initiation between sex remain an area of ongoing research. This study assesses the association between sex and the likelihood of receiving antithrombotic therapy following an AF diagnosis.

Methods

A retrospective multicenter cohort study was conducted using data from the IQVIA™ Disease Analyzer database, comprising 118 cardiology practices in Germany. Patients ≥ 18 years with a first-time AF diagnosis between 2010 and 2023 were included. The primary outcome was the prescription of vitamin K antagonists, direct thrombin inhibitors, or direct factor Xa inhibitors within 30 days post-diagnosis. Multivariable logistic regression models examined the association between sex and therapy initiation, adjusting for age, CHA₂DS₂-VA Score, and health insurance coverage.

Results

Among 166,005 patients (74,755 female, 91,250 male), female patients were significantly older than their male counterparts, with a mean age of 76.2 years compared to 73.2 years ( p < 0.001). They however had a similar median CHA 2 DS 2 -VA Score (2). Overall, the proportion of patients with antithrombotic prescriptions were lower in females (13.2%) compared to males (15.5%, p < 0.001). Multivariable regression revealed a negative association between female sex and therapy initiation (OR: 0.89; 95% CI: 0.86–0.91, p < 0.001).

Conclusion

Our findings indicate notable disparities in the initiation of antithrombotic therapy in relation to sex, thus underscoring the necessity for additional research to comprehend the underlying factors. Consequently, efforts should be concentrated on enhancing adherence to treatment guidelines, addressing sex-specific barriers to therapy, and ensuring equitable access to optimized stroke prevention strategies for patients with AF. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationFibrinolytic AgentsStrokePractice Patterns, Physicians'Healthcare DisparitiesHumansMaleFemaleGermanyAgedRetrospective StudiesSex FactorsAged, 80 and overMiddle AgedRisk Factors

Stichwörter der Autor:innen

Antithrombotic therapyAtrial fibrillationCardioembolicSex disparitiesStroke prevention

Substanzen

Fibrinolytic Agents

Autor:innen und Institutionen

  • Medical Clinic I, Cardiology and Angiology, Justus-Liebig-University, Klinikstraße 33, 35392, Giessen, Germany. Jamschid.Sedighi@innere.med.uni-giessen.de.
  • Medical Clinic I, Cardiology and Angiology, Justus-Liebig-University, Klinikstraße 33, 35392, Giessen, Germany.
  • Christian-Albrechts-University of Kiel, Kiel, Germany.
  • Department of Geriatrics and Neurology, Diakonie Hospital Jung Stilling, Siegen, Germany.
  • Department of Cardiology, Kerckhoff-Clinic, Bad Nauheim, Germany.
  • German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Rhine-Main, Germany.

Förderung

  • Justus-Liebig-Universität Gießen

Zitieren

APA

Sedighi, J., Luedde, M., Dinov, B., Bengel, P., Boettger, P., Tanislav, C., Sossalla, S., & Kostev, K. (2025). Sex differences in the initiation of antithrombotic therapy in patients with atrial fibrillation in Germany. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-025-02757-7

Vancouver

Sedighi J, Luedde M, Dinov B, Bengel P, Boettger P, Tanislav C, et al. Sex differences in the initiation of antithrombotic therapy in patients with atrial fibrillation in Germany. Clinical Research in Cardiology. 2025. doi:10.1007/s00392-025-02757-7

BibTeX
@article{Sedighi2025,
  author = {Sedighi, Jamschid and Luedde, Mark and Dinov, Boris and Bengel, Philipp and Boettger, Priyanka and Tanislav, Christian and Sossalla, Samuel and Kostev, Karel},
  title = {Sex differences in the initiation of antithrombotic therapy in patients with atrial fibrillation in Germany},
  journal = {Clinical Research in Cardiology},
  year = {2025},
  doi = {10.1007/s00392-025-02757-7}
}
Kostenlos starten →